A Study of Strengthening Teen Brain Resilience Using Music During Cancer Treatment
NCT07729384 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2026-07-27
Summary
This clinical trial tests the feasibility and acceptability of the Strengthening Teen Brain Resilience Using Music (STRUM) intervention to improve radiation induced cognitive decline for adolescents undergoing radiation therapy for cancer treatment. Adolescents treated with radiation therapy for cancer often experience persistent cognitive deficits and reduced brain resilience or the ability to preserve cognitive and emotional functioning despite stressors. Musical instrument training has been shown to enhance memory, academic skills, and emotional well-being in youth. Although guitars are often the most preferred instrument, ukuleles offer greater accessibility due to their simplicity, affordability, and suitability for younger users. The STRUM intervention consists of virtual active music therapy ukulele lessons, which may be a feasible and acceptable way to improve radiation induced cognitive decline for adolescents undergoing radiation therapy for cancer treatment.
Conditions
- Childhood Hematopoietic and Lymphatic System Neoplasm
- Childhood Malignant Solid Neoplasm
- Hematopoietic and Lymphatic System Neoplasm
- Malignant Solid Neoplasm
Interventions
- OTHER
-
Interview
Ancillary studies
- PROCEDURE
-
Music Therapy
Attend STRUM sessions
- OTHER
-
Survey Administration
Ancillary studies
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
C. Robert Bennett, PhD, RN · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 12 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-10-01
- Primary Completion
- 2028-11-01
- Completion
- 2028-11-01
Countries
- United States
Study Locations
More Related Trials
-
Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
NCT01120639 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
NCT00662506 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
NCT00042991 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas
NCT00004259 ·Status: COMPLETED ·Phase: PHASE3
-
Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma
NCT06894979 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma
NCT00058370 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma
NCT00005637 ·Status: COMPLETED ·Phase: PHASE1
-
Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma
NCT00079339 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
NCT01800695 ·Status: COMPLETED ·Phase: PHASE1
-
Prolonged Daily Temozolomide for Low-Grade Glioma
NCT00165360 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy or Temozolomide in Treating Patients With Gliomas
NCT00182819 ·Status: COMPLETED ·Phase: PHASE3
-
Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00047294 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
NCT00304031 ·Status: COMPLETED ·Phase: PHASE3
-
Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
NCT04019262 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)
NCT05685004 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis
NCT06999148 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
NCT00039494 ·Status: COMPLETED ·Phase: PHASE2
-
OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma
NCT03587038 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
NCT00887146 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Vitamin D for Treatment of Glioblastoma Multiforme
NCT01181193 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas
NCT00669669 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
NCT07185880 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma
NCT04397679 ·Status: TERMINATED ·Phase: PHASE1
-
Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
NCT06557512 ·Status: RECRUITING ·Phase: NA
-
Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas
NCT03334305 ·Status: TERMINATED ·Phase: PHASE1